ACOT2 Antibodies

Santa Cruz Biotechnology provides a broad selection of ACOT2 monoclonal antibodies for research focused on understanding acyl-CoA thioesterases. ACOT2 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ACOT2, or acyl-CoA thioesterase 2, plays a crucial role in lipid metabolism by hydrolyzing acyl-CoA esters, thereby regulating fatty acid availability and signaling pathways. ACOT2 maintains cellular energy homeostasis and has significant implications in metabolic disorders and cancer. Research into ACOT2 function continues to reveal potential therapeutic targets for various diseases. Scientists can explore the complex mechanisms of fatty acid metabolism using specific molecular tools and advanced detection methods. Investigating ACOT2's role in cellular processes helps advance understanding of metabolic regulation and disease development. ACOT2 research contributes valuable insights into potential treatments for metabolic disorders. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of lipid metabolism and its impact on human health.